‘Most Innovative’ Products Are a Magnificent Seven
Connect, San Diego’s oldest startup accelerator, recognized seven companies with ground-breaking technologies on Nov. 29. Pared down from a pool of 23 finalists by a team of judges, this year’s winners designed products that are better, faster and stronger than the competition. UF startup and UF Innovate | Sid Martin Biotech alum Banyan Biotech, named one of […]
AxoGen Announces Avance® Nerve Graft Recipient Selected to Ride on Donate Life Rose Parade® Float
UF startup and UF Innovate | Sid Martin Biotech alum AxoGen, Inc., a global leader in developing and marketing innovative surgical solutions for damage or discontinuity to peripheral nerves, announced that Madelyn Nicpon was selected to ride on the 2019 Donate Life Rose Parade® float that will be featured in the annual Tournament of Roses® parade. The […]
Connect Honors 7 New Products as ‘Most Innovative’ at Annual Awards (xconomy.com)
UF startup and UF Innovate | Sid Martin Biotech graduate company Banyan Biomarkers does have a presence in San Diego, which is why it is listed among these finalist companies “local” to Connect, a startup accelerator in that city. San Diego’s Connect, which runs a tech and life science startup accelerator, recognized seven local companies […]
Gene Therapy Offers Hope to People With Achromatopsia, an Inherited Retinal Eye Disease (Fat Pitch Financials)
UF startup AGTC, a UF Innovate | Sid Martin Biotech graduate, is recruiting for two Phase I/II clinical trials for ACHM caused by mutations in the CNGB3 or the CHGA3 gene. For years, people with inherited retinal diseases (IRDs), such as achromatopsia (ACHM), have been undiagnosed, misdiagnosed or delayed seeking genetic testing to confirm their […]
Oragenics, Inc. Announces Publication Detailing the Development of Blueprints for Designing a New Class of Anti-Infectives (BusinessWire)
UF Innovate | Sid Martin Biotech alumni company Oragenics, Inc., a clinical stage biotechnology company, announced the publication of a research paper titled “Blueprints for the rational design of therapeutic mutacin 1140 variants,” in Chemical Biology & Drug Design (CBDD). The study, which can be accessed via https://onlinelibrary.wiley.com/doi/abs/10.1111/cbdd.13365 focused on structure-activity relationships of the lantibiotic […]
Axogen Expands Addressable Market Estimate to $2.7B (Mass Device)
UF startup AxoGen, a graduate of UF Innovate | Sid Martin Biotech, updated the company’s nerve repair technology and business strategies for the coming years, saying that it believes that the total addressable market for peripheral nerve repair has grown from earlier estimates of $2.2 billion up to $2.7 billion. The Alachua-based company said that […]
RTI Surgical Announces HealthPartners’ Positive Coverage Decision for Minimally Invasive Sacroiliac Joint Fusion Surgery (Spinal News International)
UF startup RTI Surgical, a UF Innovate | Sid Martin Biotech alum, has announced that HealthPartners, the largest consumer governed non-profit healthcare organisation in the USA, issued a positive coverage decision for minimally invasive sacroiliac (SI) joint fusion surgery. This decision expands access to RTI’s SImmetry System for HealthPartners members considering treatment for SI joint […]
UF Innovate | Tech Licensing Announces Another Successful Partnership with Portfolio Company Entrinsic Health Solutions Inc. (UF News)
University of Florida startup Entrinsic Health Solutions Inc. (EHS), an innovative health sciences company, has entered into a partnership that provides for a worldwide commercial license and supply agreement for enterade®, an amino acid-based, glucose-free, electrolyte solution designed for oncology and gastrointestinal (GI) disease patients. “We are excited about this partnership,” stated Dr. Sadasivan Vidyasagar, […]
AGTC Posts Quarterly Income (Healio)
UF startup and UF Innovate | Sid Martin Biotech graduate Applied Genetic Technologies Corporation reported a net income of $1.2 million for the first quarter of its fiscal year compared with a net loss of $1.4 million in the same quarter of 2017. General and administrative expenses decreased from $3.7 million to $3.2 million, while […]
OxThera AB is Being Granted US Patent for Oxalobacter Secretagogues (PR Newswire)
UF startup OxThera AB, a privately-held Stockholm-based biopharmaceutical company, announced a granted US patent on Oxalobacter formigenes secretagogues. OxThera AB, a spinout of Ixion, is a UF Innovate | Sid Martin Biotech alumnus. Oxabact®, a formulation of highly concentrated lyophilized Oxalobacter formigenes, is being developed by OxThera AB as a potential treatment for patients with […]